MedTrace Logo

The Intersection of Oncology Care and Worker Well-Being

NCT05250284 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-11-10

No results posted yet for this study

Summary

The goals of this study will be a greater understanding of cancer patients' well-being experience through the care/treatment continuum. An important aspect of the study is an understanding of work- and treatment-related challenges experienced by low-income men, many of whom will be Latino. At the 12-month observation period, the investigators will learn whether these men work long-term and how work status relates to well-being.

Conditions

Interventions

BEHAVIORAL

WellBQ

National Institue for Occupational Safety and Health Worker Well-Being Questionnaire is comprised of 21 scales (multiple items assessing a single construct) and 31 single items that cover worker well-being. Domains include (i) work evaluation and experience, (ii) workplace policies and culture, (iii) workplace physical environment and safety climate, (iv) health status, and (v) home, community, and society.

BEHAVIORAL

PROMIS

Patient-Reported Outcomes Measurement Information System is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children.

Sponsors & Collaborators

  • National Institute for Occupational Safety and Health (NIOSH/CDC)

    collaborator FED

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Cathy Bradley · University of Colorado, Denver

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2026-05-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05250284 on ClinicalTrials.gov